Human Research Ethics Committee RESEARCH PROJECTS
Total Page：16
File Type：pdf, Size：1020Kb
Updated 10-Dec-2012
Human Research Ethics Committee RESEARCH PROJECTS
Project Title Researcher Approved Status Code Date 2012-032 Melanoma Institute Australia Bio- Associate Professor Michael Hughes 12-Nov-2012 Approved specimen bank for melanoma research Northern Surgical Oncology San Clinic Suite 404 185 Fox Valley Road Wahroonga NSW 2076
2012-031 XL 184-307: Phase 3 randomised Dr Gavin Marx 29-Oct-2012 Approved double blind controlled study of Sydney Haematology & Oncology Clinics Cabozanatinib (XL 184) vs Prednisone Clinical Trials Unit in metastatic castration resistant Sydney Adventist Hospital prostate cancer patients who have 185 Fox Valley Road received prior Docetaxel and prior Wahroonga NSW 2076 Abiraterone or MDV3100 (COMET)
2012-030 Implementation of an expanded mid- Ms Jodie Privett 29-Oct-2012 Approved meal menu service in an acute care private hospital and its impact on patients' nutritional intake and cost 2012-029 Evaluation of the Integration of carer Dr Karen Luxford 12-Nov-2012 Approved knowledge to improve inpatient care for Director, Patient Based Care dementia patients (TOP 5) Clinical Excellence Commission L 13, 227 Elizabeth Street Sydney NSW 2000
2012-028 GU09-145: Phase I/II Study of BNC105P Dr Gavin Marx 08-Oct-2012 Approved in Combination with Everolimus or Sydney Haematology & Oncology Clinics Following Everolimus for Progressive Clinical Trials Unit Metastatic Clear Cell Renal Cell Sydney Adventist Hospital Carcinoma Following Prior Tyrosine 185 Fox Valley Road Kinase Inhibitors Wahroonga NSW 2076
2012-027 FINESSE trial - Filtration in the Pending Neuropathy of End Stage Kidney Disease Symptom Evolution. A randomised, unblinded trial to assess progression of neuropathy with haemodidfiltration vs standard haemodialysis in patients with endstage kidney disease. Updated 10-Dec-2012
2012-026 Data collection on outcomes on men Associate Professor Henry Woo 22-Oct-2012 Approved with prostate cancer treated with radical Australian Clinical Trials Pty Ltd prostatectomy Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
2012-025 Data collection on outcomes on men Associate Professor Henry Woo 10-Oct-2012 Approved treated with greenlight laser surgery Australian Clinical Trials Pty Ltd Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
2012-024 A phase III study of the impact of a Dr Gavin Marx 26-Sep-2012 Approved physical activity program on disease-free Sydney Haematology & Oncology Clinics survival in patients with high risk stage II Sydney Haematology and Oncology or stage III colon cancer: a randomised Clinics controlled trial (CHALLENGE) Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
2012-023 Living Well with Prostate Cancer: A Professor Suzanne Chambers 26-Sep-2012 Approved Randomised Controlled Trial of a 553 Gregory Terrace Mindfulness Intervention for Men with Fortitude Valley Qld 4006 Advanced Prostate Cancer 2012-022 Development of Smart Phone Dr Stephanie Phillips 26-Sep-2012 Approved application for neuromuscular function Consultant Anaesthetist, monitoring Sydney Adventist Hospital Clinical School 406A San Clinic Fox Valley Road Wahroonga NSW 2076
2012-021 An international survey on what Associate Professor Henry Woo 04-Sep-2012 Approved constitutes a large prostate Australian Clinical Trials Pty Ltd Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
2012-020 An Australian Translational Study to Dr Gavin Marx 05-Aug-2012 Approved Evaluate the Prognostic Role of Sydney Haematology & Oncology Clinics Inflammatory Markers in Patients with Sydney Haematology and Oncology Metastatic Colorectal Cancer Treated Clinics with Bevacizumab (Avastin) [ASCENT] Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
2012-019 FDC116115: A prospective study of Associate Professor Henry Woo 28-Nov-2012 Approved sexual function in sexually active men Australian Clinical Trials Pty Ltd treated for BPH Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
2012-018 Has the introduction of baby friendly A/Prof John Keogh Received caesarean section influenced breast 304 SAN Clinic feeding rates at one and three months 85 Fox Valley Road post-natally? WAHROONGA NSW 2076
2012-017 Can NSW Admitted Patient Data Dr Lee Taylor 24-Jul-2012 Approved improve the quality and coverage of the Locked Bag 961 NSW Register of Congenital Conditions? NSW Ministry of Health Surveillance Methods Branch, Centre of Epidemiology and Research North Sydney NSW 2059
2012-016 A phase II, double-blind, placebo Dr Gavin Marx 09-Jul-2012 Approved controlled, randomized study of GDC- Sydney Haematology & Oncology Clinics 0941 or GDC-0980 with fulvestrant Sydney Haematology and Oncology versus fulvestrant in advanced or Clinics metastatic breast cancer in patients Clinical Trials Unit resistant to aromastase inhibitor therapy Sydney Adventist Hospital (FERGI) 185 Fox Valley Road Wahroonga NSW 2076
2012-015 Involving relatives in the care of a patient Dr Tracey Thornley 04-Jul-2012 Approved in the ICU setting; What factors impact Supervisor on this? Dean, School of Nursing Sydney The University of Notre Dame PO Box 944 Broadway NSW 2077
2012-014 The successfulness of ultrasound Dr Karen Mizia 30-Apr-2012 Approved guided removal of a Mirena device when San Ultrasound for Women the strings are not visible on speculum Sydney Adventist Hospital examination in an outpatient setting (A 185 Fox Valley Road retrospective review of cases) Wahroonga NSW 2076
2012-013 A multi-centre randomized controlled Dr Roger Harris 16-May-2012 Approved trial of early goal-directed therapy in Staff Specialist, patients presenting to the Emergency Intensive Care, Department with severe sepsis in Sydney Adventist Hospital, Australasia 185 Fox Valley Road Wahroonga NSW 2076
2012-012 A randomised, open label, multicentre, Dr Gavin Marx 12-Mar-2012 Approved Phase IIIB study comparing two Sydney Haematology & Oncology Clinics Trastuzumab dosing regimens, each in Sydney Haematology and Oncology combination with Ciplatin/Capecitabine Clinics chemotherapy, as first line therapy in Clinical Trials Unit patients with HER2-positive metastatic Sydney Adventist Hospital gastric or gastro-oesophageal junction 185 Fox Valley Road adenocarcinoma who have not received Wahroonga NSW 2076 prior treatment for metastatic disease (HELOISE) Updated 10-Dec-2012
2012-011 Assessment of spinal sagittal balance Dr Peter Wilson 18-Jun-2012 Approved parameters with EOS imaging Neurosurgical trainee 2 Gregory Avenue North Epping NSW 2121
2012-010 Promotion of health lifestyle and risk Dr Erica James 12-Mar-2012 Approved modification for cancer survivors and School of Medicine & Public Health their partners / caregivers (ENRICH: Faculty of Health Exercise and Nutrition Routine Level 2, David Maddison Building Improving Cancer Health) Callaghan NSW 2308
2012-009 Survey of nursing attitudes to residual Dr Paul Stewart 05-Mar-2012 Approved neuromuscular blockade and reversal AMO Consultant Anaesthesia
PO Box 82 Wahroonga NSW 2076
2012-008 The effect of high potency Omega-3 Jade Guest 28-Mar-2012 Approved (Omacor) on markers of oxidative stress and inflammation 2012-007 Understanding clergy-parishioner Mr Dallas O'Connor 12-Mar-2012 Approved relationships - when things 'go wrong' - Associate Director of Safe Place Services Phase 1 Seventh-day Adventist Church (AUC) Ltd PO Box 650 Wahroonga NSW 2076
2012-006 Progesterone action in the human breast Professor Christine Clarke 20-Mar-2012 Approved unknown Westmead NSW 2145
2012-005 Prospective Evaluation of Various Archived - Withdrawn Uterine Prolapse Surgical Techniques in Nepalii Women 2012-004 A retrospective analysis of outcomes Archived - Withdrawn following abdominal hysteropexy for uterine prolapse in Nepal (Maharati 1) 2012-003 The Study of Heart and Renal Protection Dr Meg Jardine 23-Apr-2012 Approved - Extended Review - SHARP-ER PO Box M201 Missenden Road
Camperdown NSW 2050
2012-002 Designing a Prototype Clinical Chris Williams 16-Jan-2012 Approved Information System (CIS) for Chief Information Officer Multidisciplinary Teams During Clinical Sydney Adventist Hospital Handover in Palliative Oncology 185 Fox Valley Rd
Wahroonga NSW 2076
2012-001 Safety and Feasibility of a Transurethral Associate Professor Henry Woo 02-Feb-2012 Approved Endoscopic Procedure for the Luminal Australian Clinical Trials Pty Ltd Restoration of the Prostatic Urethra: A Australian Clinical Trials Pty Ltd Preliminary Investigation Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
2011-043 Evaluating the utility of a patient decision Associate Professor Henry Woo 30-Jan-2012 Approved aid for prospective participants in the Australian Clinical Trials Pty Ltd TROG RAVES prostate cancer trial. Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
2011-042 The complexity of treating women with Ms Catrina Ross 05-Dec-2011 Approved breast cancer, who have underlying McGrath Breast Care Nurse mental health issues. 2011-041 Evaluating the effectiveness of a Professor John Watson 28-Mar-2012 Approved strategy to increase the adoption of best Associate Dean evidence practice. A cluster randomised Sydney Adventist Hospital Clinical School controlled trial in acute stroke care
2011-040 Evaluation of a 12 week Yoga Prof Hosen Kiat 13-Feb-2012 Approved Intervention on Negative Affective Medical Director SAH Cardiac States, Cardiovascular and Cognitive Rehabilitation Program Function in Post-Cardiac Rehabilitation Cardiac Health Institute Patients 173 Shaftsbury Road Eastwood NSW 2122
2011-039 Characterization of the acute Dr Ross Grant 16-Jan-2012 Approved postprandial effect of energy dense CEO - Australasian Research Institute foods on key markers of oxidative stress Australasian Research Institute and inflammation 185 Fox Valley Road Wahroonga NSW 2076
2011-038 Arm-to-arm variation when evaluating Dr Paul Stewart 10-Oct-2011 Archived - Study neuromuscular block: An analysis of the AMO Complete precision and the bias and agreement Consultant Anaesthesia between arms when using Electromyography in abductor digiti PO Box 82 minimi and first dorsal Interosseous. Wahroonga NSW 2076
2011-037 Arm-to-arm variation when evaluating Dr Paul Stewart Disposed neuromuscular block: An analysis of the AMO precision and the bias and agreeement Consultant Anaesthesia between arms when using Kinemyography PO Box 82 Wahroonga NSW 2076
2011-036 Retrospective Audit of Post-Operative Dr Stephanie Phillips 17-Oct-2011 Approved Analgesia after Ivor Lewis Oesophago- Consultant Anaesthetist, gastrectomy Sydney Adventist Hospital Clinical School 406A San Clinic Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
2011-035 Randomized, open Label Multi-Centre Dr Gavin Marx 12-Sep-2011 Approved Study Comparing Cabazitaxel at Sydney Haematology & Oncology Clinics 20mg/m2 and at 25 mg/m2 Every 3 Sydney Haematology and Oncology weeks in Combination with Prednisone Clinics for the Treatment of Metastatic Clinical Trials Unit Castration Resistant Prostate Cancer Sydney Adventist Hospital Previously Treated with Docetaxel 185 Fox Valley Road Containing Regimen (PROSELICA). Wahroonga NSW 2076
2011-034 Randomized, Open Label, MultiCentre, Dr Gavin Marx 12-Sep-2011 Approved Study comparing Cabazitaxel at 25 Sydney Haematology & Oncology Clinics mg/m2 and at 20 mg/m2 in Combination Sydney Haematology and Oncology with Prednisone Every 3 Weeks to Clinics Docetaxel in Combination with Clinical Trials Unit Prednisone in Patients with Metastatic Sydney Adventist Hospital Castration Resistant Prostate Cancer 185 Fox Valley Road not Pre-treated with Chemotherapy Wahroonga NSW 2076 (FIRSTANA)
2011-033 A randomized, double-blind, placebo- Dr Greg Fulcher 12-Sep-2011 Approved controlled, parallel group, multicenter study to evaluate cardiovascular outcomes during treatment with Lixisenatide in type 2 diabetic patients after an Acute Coronary Syndrome. 2011-032 A phase III multi-centre, randomised trial Dr Amy Teh 30-Oct-2011 Approved comparing adjuvant radiotherapy (RT) Consultant in Radiation Oncology with early salvage RT in patients with Radiation Oncology Institute positive margins or extraprostatic Radiation Oncology Institute disease following radical prostatectomy 185 Fox Valley Road (RAVES) Wahroonga NSW 2076
2011-031 To investigate the ten year re-treatment Associate Professor Henry Woo 05-Sep-2011 Approved rate after bladder neck incision (BNI) or Australian Clinical Trials Pty Ltd transurethral incision of the prostate Australian Clinical Trials Pty Ltd (TUIP) for outlet obstruction. Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
2011-030 Clinical study to evaluate a scaffold Associate Professor Desmond Bokor 05-Sep-2011 Suspended implant for rotator cuff lesions Principal Investigator - SAH encountered on the supraspinatus Specialty Orthopaedics tendon (CIRCLES) 116 Macquarie Street Parramatta NSW 2150
2011-029 An open label study of Abiraterone Dr Gavin Marx 04-Jul-2011 Approved Acetate in subjects with metastatic Sydney Haematology & Oncology Clinics castration-resistant prostate cancer who Sydney Haematology and Oncology have progressed after Taxane-based Clinics chemotherapy. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
2011-028 Incidence of residual neuromuscular Dr Paul Stewart 18-Feb-2011 Approved blockade in Australian post anaesthetic AMO care units Consultant Anaesthesia
PO Box 82 Wahroonga NSW 2076
2011-027 A Phase 3, Randomized, Double-blind, Dr Gavin Marx 20-Jun-2011 Approved Multicenter Trial Comparing Orteronel Sydney Haematology & Oncology Clinics (TAK-700) Plus Prednisone With Sydney Haematology and Oncology Placebo Plus Prednisone in Patients Clinics With Metastatic Castration-Resistant Clinical Trials Unit Prostate Cancer that has progressed Sydney Adventist Hospital During or Following Docetaxel-based 185 Fox Valley Road Therapy. Wahroonga NSW 2076
2011-026 The pharmacokinetic differences in Dr Ross Grant 29-Aug-2011 Approved serum and saliva levels of resveratrol, CEO - Australasian Research Institute lycopene complex, NAD+ and oxidative Australasian Research Institute stress. 185 Fox Valley Road Wahroonga NSW 2076
2011-025 Do whole and/or highly processed foods Dr Ross Grant Archived - Rejected or food ingredients promote adverse CEO - Australasian Research Institute physiological responses? Australasian Research Institute 185 Fox Valley Road Wahroonga NSW 2076
2011-024 Improving psychosocial outcomes for Dr Joanne Shaw 20-Jun-2011 Approved carers of people with cancer: a Surgical Outcomes Research Centre randomised controlled trial Building 89 Level 9 PO Box M157 Missenden Road NSW 2050
2011-023 A Phase 3, randomized, double-blind Dr Gavin Marx 13-Jun-2011 Approved trial of Pegylated Liposomal Doxorubicin Sydney Haematology & Oncology Clinics (PLD) plus AMG 386 or placebo in Sydney Haematology and Oncology women with recurrent partially platinum Clinics sensitive or resistant epithelial ovarian, Clinical Trials Unit primary peritoneal or fallopian tube Sydney Adventist Hospital cancer. 185 Fox Valley Road Wahroonga NSW 2076
2011-022 Direct intra-patient comparison of Dr Paul Stewart 14-Jun-2011 Approved evoked electromyography and AMO acceleromyography during induced Consultant Anaesthesia neuromuscular blockade in anaesthetised humans. PO Box 82 Wahroonga NSW 2076
2011-021 Direct intra-patient comparison of Dr Paul Stewart 14-Jun-2011 Approved evoked electromyography and AMO kinemyography during induced Consultant Anaesthesia neuromuscular blockade in anaesthetised humans. PO Box 82 Wahroonga NSW 2076 Updated 10-Dec-2012
2011-020 Comparison of evoked Dr Paul Stewart 14-Jun-2011 Approved electromyographic responses in three AMO different muscle groups of the hand Consultant Anaesthesia following induced muscle relaxation in humans under general anaesthesia. PO Box 82 Wahroonga NSW 2076
2011-019 Comparison of gastric volumes and pH Dr Paul Stewart 14-Jun-2011 Approved in lean and obese patients, determined AMO by endoscopy. Consultant Anaesthesia
PO Box 82 Wahroonga NSW 2076
2011-018 PREVAIL: A multinational Phase 3, Dr Gavin Marx 30-May-2011 Approved randomized, double-blind placebo- Sydney Haematology & Oncology Clinics controlled efficacy and safety study of Sydney Haematology and Oncology oral MDV3100 in chemotherapy-naive Clinics patients with progressive metastatic Clinical Trials Unit prostate cancer who have failed Sydney Adventist Hospital androgen deprivation therapy 185 Fox Valley Road (MDV3100-03) Wahroonga NSW 2076
2011-017 Current practice of neuro-muscular Dr Stephanie Phillips 06-Jun-2011 Approved blockade in Australia. A cross-sectional Consultant Anaesthetist, survey of attitudes and practice of Sydney Adventist Hospital Clinical School anaesthetists in 2011. 406A San Clinic Fox Valley Road Wahroonga NSW 2076
2011-016 Bi-National Colorectal Cancer Audit Dr Stuart Pincott 06-Jun-2011 Approved 2011-015 Multicentre, single-arm, open label, Dr Gavin Marx 09-May-2011 Approved clinical trial intended to provide early Sydney Haematology & Oncology Clinics access to Cabazitaxel in patients with Sydney Haematology and Oncology metastatic hormone refractory prostate Clinics cancer previously treated with a Clinical Trials Unit Docetaxel-containing regimen and to Sydney Adventist Hospital document safety of Cabazitaxel in these 185 Fox Valley Road patients (Cabazitaxel clinical trial) Wahroonga NSW 2076
2011-014 Phase II study to investigate the ability of Dr Gavin Marx 19-Apr-2011 Approved macrophage inhibitory cytokine-1 (MIC- Sydney Haematology & Oncology Clinics 1) and associated plasma biomarkers to Sydney Haematology and Oncology predict response to chemotherapy in Clinics patients with metastatic hormone- Clinical Trials Unit refractory prostate cancer. Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
2011-013 The Australian diabetes, obesity and Dr Elizabeth Barr 20-Apr-2011 Approved lifestyle study Epidemiologist Baker IDI Heart & Diabetes Institute Tues/Frid Updated 10-Dec-2012
2011-012 Attitudes of SAN community to clinical Dr Stephanie Phillips 11-Apr-2011 Approved student teaching in a private hospital Consultant Anaesthetist, setting. Sydney Adventist Hospital Clinical School 406A San Clinic Fox Valley Road Wahroonga NSW 2076
2011-011 Porto Cath insertion Dr Sumit Lumba Archived - Rejected Medical Oncology Advanced Trainee under Dr Eisen Liang and Dr Gavin Marx
2011-010 Grounded theory research investigating Prof Elizabeth More 30-May-2011 Approved organisational change in specified PhD Supervisor Australian hospitals to determine the applicability of existing generic organisational change management models to the not-for-profit hospital environment. 2011-009 Randomised controlled double-blind trial Dr Stephanie Phillips Archived - Abandoned of targeted intra-crural ropivicaine for Consultant Anaesthetist, post-operative analgesia after Sydney Adventist Hospital Clinical School laparoscopic fundoplication. 406A San Clinic Fox Valley Road Wahroonga NSW 2076
2011-008 A pilot study to evaluate a new blood Associate Professor Henry Woo 30-May-2011 Approved test for the detection of prostate cancer Australian Clinical Trials Pty Ltd using antibody arrays. Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
2011-007 Rhinology Tissue Bank A/Prof Richard Harvey 11-Jul-2011 Approved St Vincent's Hospital Sydney Ear Nose & Throat Clinic Sydney Ear Nose & Throat Clinic 354 Victoria Street Darlinghurst NSW 2010
2011-006 Assessment of the effect of oral Dr Ross Grant 06-Jun-2011 Approved supplementation with resveratrol and/or CEO - Australasian Research Institute lycopene on key markers of oxidative Australasian Research Institute stress over time and skin health 185 Fox Valley Road following acute UV exposure. Wahroonga NSW 2076
2011-005 Quantification of key markers of Dr Ross Grant 24-May-2011 Approved oxidative stress and inflammation in CEO - Australasian Research Institute human cerebrospinal fluid and Australasian Research Institute correlation with diet, lifestyle and 185 Fox Valley Road psychosocial factors across the age Wahroonga NSW 2076 range: Part 2. Updated 10-Dec-2012
2011-004 Incidence and management of Dr Stephanie Phillips 21-Feb-2011 Approved capnothorax during laparoscopic Consultant Anaesthetist, massive hiatus hernia repair. Sydney Adventist Hospital Clinical School 406A San Clinic Fox Valley Road Wahroonga NSW 2076
2011-003 - Archived - Never Approved
2011-002 Patterns of care in patients with Prof Dianne O’Connell 25-Jan-2011 Approved pancreatic cancer (POCS Pancreas Senior Epidemiologist, NSW). Cancer Council NSW
Cancer Council PO Box 572 Kings Cross NSW 1340
2011-001 Cell type specific biologic responses to Professor Anthony Cunningham 19-Jan-2011 Approved HIV infection Westmead Millennium Institute Westmead Millenium Institute PO Box 412 Westmead NSW 2145
28/10 Study to assess the incidence and Dr Ross Grant 08-Dec-2010 Archived - Study efficacy of treatment of Helicobacter CEO - Australasian Research Institute Complete pylori infection in a representative Australasian Research Institute population from the Gyuto Monastery in 185 Fox Valley Road Northern India. Wahroonga NSW 2076
27/10 A randomized, multicentre, open-label, Dr Gavin Marx 10-Dec-2010 Approved Phase 3 study to compare the efficacy Sydney Haematology & Oncology Clinics and safety of Panitumumab and Sydney Haematology and Oncology Cetuximab in subjects with previously Clinics treated, wild-type KRAS, metastatic Clinical Trials Unit colorectal cancer. Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
26/10 Establishment of a neuro and endocrine Professor Bruce Robinson 13-Dec-2010 Approved tumour and tissue bank within the The University Clinic Department of Cancer Genetics, Kolling Wallace Freeborn Professorial Block, Institute and the University of Sydney Royal North Shore Hospital Endocrine Surgical Unit. St Leonards NSW 2065
25/10 Age related changes in NAD+ Dr Ross Grant 08-Dec-2010 Approved metabolism, oxidative stress and Sirtuin CEO - Australasian Research Institute activity in human muscle. Australasian Research Institute 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
24/10 A prospective non-interventional study to Associate Professor Henry Woo 25-Jan-2011 Approved evaluate the effect of Triptorelin Australian Clinical Trials Pty Ltd Embonate (Diphereline 11.25mg) on Australian Clinical Trials Pty Ltd lower urinary tract symptoms (LUTS) in Suite 406 SAN Clinic Australian prostate cancer patients. 185 Fox Valley Road Wahroonga NSW 2076
23/10 PREVAIL: A multinational Phase 3, Associate Professor Henry Woo 02-Feb-2011 Approved randomized, double-blind, placebo- Australian Clinical Trials Pty Ltd controlled efficacy and safety study of Australian Clinical Trials Pty Ltd oral MDV3100 in chemotherapy-naïve Suite 406 SAN Clinic patients with progressive metastatic 185 Fox Valley Road prostate cancer who have failed Wahroonga NSW 2076 androgen deprivation therapy (MDV3100-03)
22/10 Prospective study to investigate the Dr Gavin Marx 05-Sep-2010 Approved ability of the GSTP1 methylation assay Sydney Haematology & Oncology Clinics to assess response to chemotherapy in Sydney Haematology and Oncology patients with metastatic hormone- Clinics refractory prostate cancer. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
21/10 Cancer multidisciplinary team research Dr Genevieve Baratiny 22-Sep-2010 Approved project. Visiting Research Fellow Discipline of General Practice, University of Adelaide North Terrace SA 5005
20/10 A randomized, double-blind, placebo- Dr Gavin Marx 23-Aug-2010 Approved controlled, multi-centre phase 3 study of Sydney Haematology & Oncology Clinics Denosumab as adjuvant treatment for Sydney Haematology and Oncology women with early-stage breast cancer at Clinics high risk of recurrence. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
19/10 Advisa Dr MRI pacing system clinical Dr Peter Illes Archived - Rejected study. 5 Bruce Street Mona Vale NSW 2103
18/10 Modular-choice secondary prevention Dr Julie Redfern 15-Jul-2010 Approved following acute coronary syndrome: a Senior Research Fellow randomised multicentre trial. The George Institute for Global Health, PO Box M201 Missenden Road NSW 2050 Updated 10-Dec-2012
17/10 Pilot study to assess the efficacy of Dr Ross Grant 30-Jun-2010 Approved naturally enhanced soy powder to CEO - Australasian Research Institute reduce fasting blood glucose levels in Australasian Research Institute humans. 185 Fox Valley Road Wahroonga NSW 2076
16/10 A multicentre, controlled trial to Prof Rodney Lane 30-Jun-2010 Approved determine the safety and efficacy of Suite 13 Greenwich Square, hypertensive extracorporeal limb 130-134 Pacific Highway perfusion (HELP) in treating patients St Leonards NSW 2065 with critical limb ischaemia. 15/10 Improved cord blood stem cell recovery Belinda Pope 30-Jun-2010 Approved through the characterization of upstream Quality Manager factors contributing to final post thaw Stem Cell Unit, viability – Part II. L5 Pathology, Sydney Adventist Hospital, 185 Fox Valley Road Wahroonga NSW 2076
14/10 Clinical results of dynamic hip screws A/Prof Nigel Hope 08-Jun-2010 Approved versus proximal femoral nails for Suite 11, intratrochanteric fractures. 4 Young St Neutral Bay NSW 2089
13/10 Assessment of senior adults in oncology. Dr Gavin Marx 31-May-2010 Approved A prospective audit of clinical practice in Sydney Haematology & Oncology Clinics Australian oncology units. Sydney Haematology and Oncology Clinics Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
12/10 Establishing the factors that contribute to Prof Geoff Delaney 24-May-2010 Approved a shortfall in evidence-based Director Radiation Oncology, radiotherapy. Western Zone, Sydney South West Area Health Service Liverpool Hospital Cancer Therapy Centre, Locked Bag 7103 Liverpool BC NSW 1871
11/10 A Randomized Double-Blind Phase 3 Dr Gavin Marx 03-May-2010 Approved Trial Comparing Docetaxel Combined Sydney Haematology & Oncology Clinics with Dasatinib to Docetaxel Combined Sydney Haematology and Oncology with Placebo in Castration-Resistant Clinics Prostate Cancer. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
10/10 The impact of San Day Infusion Centre Ms Anne Temblett 23-Apr-2010 Approved treatment on the experience of pain, Director of Medical Care Services anxiety, nausea and fatigue in cancer (Nursing) patients. 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
09/10 Consumer perspectives regarding Dr Paul Collett 13-Apr-2010 Approved dialysis treatment. Director of Nephrology Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
08/10 Validation study of recurrent postpartum Dr Jane Ford 15-Jun-2010 Approved haemorrhage and associated factors as University of Sydney, reported in the admitted patient data Dept of Obstetrics & Gynaecology, collection and midwives data collections Level 2, 2002-2006 (validated against medical Building 52, records). Royal North Shore Hospital St Leonards NSW 2065
07/10 Patient Journey Review Lillian Stibbs 29-Mar-2010 Approved Quality Management Officer, San Day Surgery Hornsby, c/o 22 Moolanda Avenue West Pennant Hills NSW 2126
06/10 Prayer request form study Ms Kristina Mazzaferri 29-Mar-2010 Approved Senior Chaplain Sydney Adventist Hospital, 185 Fox Valley Road Wahroonga NSW 2076
05/10 Improved cord blood stem cell recovery Belinda Pope 26-Feb-2010 Approved through the characterization of upstream Quality Manager factors contributing to final post thaw Stem Cell Unit, viability. L5 Pathology, Sydney Adventist Hospital, 185 Fox Valley Road Wahroonga NSW 2076
04/10 A multi-centre, prospective controlled Associate Professor Henry Woo 24-Mar-2010 Approved trial on the incidence of retrograde Australian Clinical Trials Pty Ltd ejaculation post photoselective Australian Clinical Trials Pty Ltd vaporisation prostatectomy (PVP) Suite 406 SAN Clinic compared to diathermy transurethral 185 Fox Valley Road resection of the prostate (TURP). Wahroonga NSW 2076
03/10 The IMPACT of Biotronik home Dr Peter Illes 30-Jun-2010 Approved monitoring guided anticoagulation on 5 Bruce Street stroke risk in patients with ICD and CRT- Mona Vale NSW 2103 D devices. 02/10 Health-related outcomes of valve Dr Robyn Gallagher 03-Feb-2010 Approved surgery for rheumatic heart disease University of Technology, performed by a volunteer humanitarian Sydney team in Fiji. University of Technology Level 7, Building 10 City Campus PO Box 123
BROADWAY NSW 2007 Updated 10-Dec-2012
01/10 A preliminary investigation into primary Dr Ross Grant 30-Jun-2010 Approved causes of oxidative stress in the brain CEO - Australasian Research Institute and its impact on vital neuronal cell Australasian Research Institute biochemistry. 185 Fox Valley Road Wahroonga NSW 2076
25/09 Ovarian cancer patterns of care survey – A/Prof Penelope Webb 14-Dec-2009 Approved NSW Queensland Institute of Medical Research, Cancer & Population Studies Unit, PO Royal Brisbane Women’s Hospital Herston QLD 4029
24/09 AG0507GS: A multicentre phase II study Dr Gavin Marx 30-Nov-2009 Recruitment Ceased of Risk Evaluation in GIST with Selective Sydney Haematology & Oncology Clinics Therapy Escalation for Response. Sydney Haematology and Oncology (REGISTER) Clinics Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
23/09 Cancer incidence in recipients of Dr Lesley Ashton 01-Dec-2009 Approved haematopoietic stem cell transplantation Children’s Cancer Institute Australia, in Australia PO Box 81 Randwick NSW 2032
22/09 Investigation into the effect of patient Dr Adrian Smith 09-Nov-2009 Approved body habitus on quality of mesorectal resection in rectal cancer. 21/09 A Phase 3, randomized, double-blind, Dr Gavin Marx 04-Nov-2009 Approved placebo-controlled study of Abiraterone Sydney Haematology & Oncology Clinics Acetate (CB7630) plus Prednisone in Sydney Haematology and Oncology asymptomatic or mildly symptomatic Clinics patients with metastatic castration- Clinical Trials Unit resistant prostate cancer. Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
20/09 Case studies with muscle relaxants Dr Paul Stewart 27-Oct-2009 Approved reversal agents. AMO Consultant Anaesthesia
PO Box 82 Wahroonga NSW 2076
19/09 The Australian Maternity Outcomes A/Prof Sullivan 10-Mar-2010 Approved Surveillance System (AMOSS): Director, Improving the safety and quality of Perinatal & Reproductive, maternity care in Australia. Epidemiology Research Unit, School of Women’s and Children’s Health, Faculty of Medicine, University of New South Wales Updated 10-Dec-2012
18/09 Pilot study to assess the incidence and Dr Ross Grant 14-Oct-2009 Archived - Study efficacy of treatment of Helicobacter CEO - Australasian Research Institute Complete pylori infection in a representative Australasian Research Institute population from the Gyuto Monastery in 185 Fox Valley Road Northern India. Wahroonga NSW 2076
17/09 Early parenteral nutrition versus Dr Roger Harris 14-Oct-2009 Study Complete standard care in the critically ill patient: A Staff Specialist, level I randomised controlled trial. Intensive Care, Sydney Adventist Hospital, 185 Fox Valley Road Wahroonga NSW 2076
16/09 A double-blind, placebo-controlled study Associate Professor Henry Woo 14-Oct-2009 Approved to evaluate new or worsening lens Australian Clinical Trials Pty Ltd opacifications in subjects with non- Australian Clinical Trials Pty Ltd metastatic prostate cancer receiving Suite 406 SAN Clinic Denosumab for bone loss due to 185 Fox Valley Road androgen-deprivation therapy. Wahroonga NSW 2076
15/09 A Phase III, randomised, placebo- Associate Professor Henry Woo 14-Oct-2009 Study Complete controlled, double-blind study to assess Australian Clinical Trials Pty Ltd the efficacy and safety of one-daily orally Australian Clinical Trials Pty Ltd administered ZD4054 10mg in non- Suite 406 SAN Clinic metastatic hormone-resistant prostate 185 Fox Valley Road cancer patients. Wahroonga NSW 2076
14/09 A double-blind, randomised, multiple Associate Professor Henry Woo 14-Oct-2009 Study Complete dose, phase III, multicentre study of Australian Clinical Trials Pty Ltd Alpharadin in the treatment of patients Australian Clinical Trials Pty Ltd with symptomatic hormone refractory Suite 406 SAN Clinic prostate cancer with skeletal 185 Fox Valley Road metastases. Wahroonga NSW 2076
12/09 A prospective, randomized, double-blind, Dr Gavin Marx 14-Aug-2009 Study Complete placebo-controlled Phase III study of Sydney Haematology & Oncology Clinics Modafinil to improve fatigue and quality Sydney Haematology and Oncology of life (QOL) in patients treated with Clinics Docetaxel-based chemotherapy for Clinical Trials Unit metastatic breast or prostate cancer – Sydney Adventist Hospital MOTIF (Modafinil in Taxotere® - 185 Fox Valley Road Induced Fatigue). Wahroonga NSW 2076 Updated 10-Dec-2012
11/09 Botox injection for treatment of chronic Associate Professor Henry Woo Archived - Abandoned prostate pain Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
10/09 The NSW Cancer, Lifestyle and Dr Gavin Marx 27-Jul-2009 Approved Evaluation of Risk (CLEAR) study. Sydney Haematology & Oncology Clinics Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
09/09 Continuous ST segment monitoring and Dr Peter Illes 06-Jul-2009 Approved incidence of clinical events in ICD 5 Bruce Street patients – AnalyST Registry Mona Vale NSW 2103
08/09 An observational, multicentre, open Dr Gavin Marx 06-Jul-2009 Study Complete label, non-interventional programme to Sydney Haematology & Oncology Clinics assess the long-term safety and efficacy Sydney Haematology and Oncology of Somatuline® Autogel® in the Clinics treatment of NET when administered by Clinical Trials Unit patients or their partners (“home Sydney Adventist Hospital injection group”) or administered by 185 Fox Valley Road healthcare professionals. Wahroonga NSW 2076
07/09 Prediction of cardiotoxicity by Dr Gavin Marx 08-Jun-2009 Approved measurement of serum N-terminal pro- Sydney Haematology & Oncology Clinics B-type natriuretic peptide levels in breast Sydney Haematology and Oncology cancer patients receiving adjuvant Clinics Trastuzumab (CATS) Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
06/09 A Phase Ib/II study to assess the safety Dr Gavin Marx 11-May-2009 Approved and efficacy of AMG102 in combination Sydney Haematology & Oncology Clinics with Mitoxantrone and Prednisone in Sydney Haematology and Oncology subjects with previously treated castrate Clinics resistant prostate cancer (AMG102) Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
05/09 A multi-centre, randomized, double- Dr Gavin Marx 11-May-2009 Study Complete blind, phase 3 study of sunitinib plus Sydney Haematology & Oncology Clinics prednisone versus prednisone in Sydney Haematology and Oncology patients with progressive metastatic Clinics hormone-refractory prostate cancer after Clinical Trials Unit failure of a docetaxel-based Sydney Adventist Hospital chemotherapy regimen. 185 Fox Valley Road Wahroonga NSW 2076
04/09 Characterisation of the effect of Ms Hemani Trevidi 13-May-2009 Study Complete polyphenol fortified red grape juice on Dept Pharmacology, markers of oxidative stress and redox University of NSW, potential in healthy human subjects. 203 Wallace Wurth Building
03/09 Focus groups conducted by Marketing, Ms Julie Behrens 18-Mar-2009 Approved PR & Business Development Director of Marketing, PR & Business Development Sydney Adventist Hospital, 185 Fox Valley Road Wahroonga NSW 2076
02/09 ACTIVE dialysis – A Clinical Trial of Dr Paul Collett 01-Jul-2009 Recruitment Ceased IntensiVE Dialysis. A multicentre, Director of Nephrology unblended, randomised, controlled trial Sydney Adventist Hospital to assess quality of life, clinical 185 Fox Valley Road outcomes and cost utility for extended vs Wahroonga NSW 2076 standard duration of dialysis in patients with end stage kidney disease 01/09 Long-term follow-up of efficacy of Associate Professor Henry Woo 22-Mar-2009 Study Complete transurethral resection of the prostate. Australian Clinical Trials Pty Ltd Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
33/08 A multicentre, open-label, randomised, Dr Gavin Marx 01-Apr-2008 Study Complete phase III trial comparing immediate Sydney Haematology & Oncology Clinics adjuvant hormonal therapy (Eligard – Sydney Haematology and Oncology leuprolide acetate)) in combination with Clinics Taxotere (cocetaxel) administered every Clinical Trials Unit three weeks versus hormonal therapy Sydney Adventist Hospital alone versus deferred therapy followed 185 Fox Valley Road by the same therapeutic options in Wahroonga NSW 2076 patients with prostate cancer at high risk of relapse after radical prostatectomy.
32/08 A phase III randomised study of Brivanib Dr Gavin Marx 01-Apr-2008 Approved Alaninate (BMS 582664) in combination Sydney Haematology & Oncology Clinics with Cetuximab (Erbitux, C225) versus Sydney Haematology and Oncology placebo in combination with Cetuximab Clinics in patients previously treated with Clinical Trials Unit combination chemotherapy for Sydney Adventist Hospital metastatic colorectal carcinoma. 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
31/08 A randomized, double-blind, multicentre Dr Gavin Marx 01-Apr-2008 Study Complete study of denosumab compared with Sydney Haematology & Oncology Clinics zoledronic acid (Zometa) in the Sydney Haematology and Oncology treatment of bone metastases in Clinics subjects with advanced breast cancer. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
30/08 A Phase III, randomised, double-blind Dr Gavin Marx 01-Apr-2008 Study Complete study to assess the efficacy and safety Sydney Haematology & Oncology Clinics of 10mg ZD4054 versus placebo in Sydney Haematology and Oncology patients with hormone resistant prostate Clinics cancer and bone metastasis who are Clinical Trials Unit pain free or mildly symptomatic. Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
29/08 RIBBON study – A Phase III multicentre, Dr Gavin Marx 01-Apr-2008 Study Complete randomised, placebo-controlled trial Sydney Haematology & Oncology Clinics evaluating the efficacy and safety of Sydney Haematology and Oncology Bevacizumab in combination with Clinics chemotherapy regimens in subjects with Clinical Trials Unit previously treated metastatic breast Sydney Adventist Hospital cancer. 185 Fox Valley Road Wahroonga NSW 2076
28/08 A randomized, double-blind, multicentre, Dr Gavin Marx 01-Apr-2008 Study Complete Phase III study to compare the efficacy Sydney Haematology & Oncology Clinics and safety of AZD2171 when added to Sydney Haematology and Oncology 5-fluorouracil, leucovorin and oxaliplatin Clinics (FOLFOX) or capecitabine and Clinical Trials Unit oxaliplatin (XELOX) with the efficacy and Sydney Adventist Hospital safety of placebo when added to 185 Fox Valley Road FOLFOX or XELOX in patients with Wahroonga NSW 2076 previously untreated metastatic colorectal cancer. Protocol D8480C0051
27/08 A Phase 3, multicentre, randomized, Dr Gavin Marx 01-Apr-2008 Study Complete placebo-controlled, double-blind trial of Sydney Haematology & Oncology Clinics AMG 706 in combination with Paclitaxel Sydney Haematology and Oncology and Carboplatin for advanced non-small Clinics cell lung cancer. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
26/08 A multicentre, randomized, double-blind Dr Gavin Marx 01-Apr-2008 Approved study comparing the efficacy and safety Sydney Haematology & Oncology Clinics of aflibercept versus placebo Sydney Haematology and Oncology administered every 3 weeks in patients Clinics treated with Docetaxel/Prednisone for Clinical Trials Unit metastatic androgen-independent Sydney Adventist Hospital prostate cancer. 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
25/08 A double-blind, randomised, multicentre, Dr Gavin Marx 01-Apr-2008 Study Complete Phase III study of Bevacizumab in Sydney Haematology & Oncology Clinics combination with Capecitabine and Sydney Haematology and Oncology Cisplatin versus placebo in combination Clinics with Capecitabine and Cisplatin, as first- Clinical Trials Unit line therapy in patients with advanced Sydney Adventist Hospital gastric cancer. 185 Fox Valley Road Wahroonga NSW 2076
24/08 A phase III open label, randomized, two- Dr Gavin Marx 01-Apr-2008 Approved parallel-arm multicentre study of E7389 Sydney Haematology & Oncology Clinics versus Capecitabine in patients with Sydney Haematology and Oncology locally advanced or metastatic breast Clinics cancer previously treated with Clinical Trials Unit anthracyclines and taxanes and Sydney Adventist Hospital refractory to the most recent 185 Fox Valley Road chemotherapy. Wahroonga NSW 2076
23/08 A randomised, double-blind, multicentre Dr Gavin Marx 01-Apr-2008 Study Complete study of denosumab compared with Sydney Haematology & Oncology Clinics zoledronic acid (Zometa) in the Sydney Haematology and Oncology treatment of bone metastases in Clinics subjects with advanced cancer Clinical Trials Unit (Excluding breast and prostate cancer) Sydney Adventist Hospital or multiple myeloma. 185 Fox Valley Road Wahroonga NSW 2076
22/08 A randomized, double-blind, multi-centre Dr Gavin Marx 01-Apr-2008 Study Complete study of Denosumab compared with Sydney Haematology & Oncology Clinics Zoledronic Acid (Zometa) in the Sydney Haematology and Oncology treatment of bone metastases in men Clinics with hormone-refractory prostate cancer. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
21/08 A randomised, open-label, multicentre Dr Gavin Marx 01-Apr-2008 Approved study to evaluate the efficacy and safety Sydney Haematology & Oncology Clinics of Bevacizumab in combination with Sydney Haematology and Oncology Trastuzumab/Docetaxel compared with Clinics Trastuzumab/Docetaxel alone as first Clinical Trials Unit line treatment for patients with HER2 Sydney Adventist Hospital positive locally recurrent or metastatic 185 Fox Valley Road breast cancer. Wahroonga NSW 2076
20/08 A randomised, multi-centre, Phase 3 Dr Gavin Marx 01-Apr-2008 Study Complete study to compare the efficacy of Sydney Haematology & Oncology Clinics panitumumab in combination with Sydney Haematology and Oncology chemotherapy to the efficacy of Clinics chemotherapy alone in patients with Clinical Trials Unit previously treated metastatic colorectal Sydney Adventist Hospital cancer. 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
19/08 A randomised double-blind, placebo- Dr Gavin Marx 01-Apr-2008 Study Complete controlled, multi-centre Phase 3 study of Sydney Haematology & Oncology Clinics Denosumab on prolonging bone Sydney Haematology and Oncology metastasis-free survival in men with Clinics hormone- refractory prostate cancer. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
18/08 A prospective, multicentre, randomized Dr Gavin Marx 01-Apr-2008 Archived - Discontinued trial of carboplatin flat dosing versus Sydney Haematology & Oncology Clinics intrapatient dose escalation in first line Sydney Haematology and Oncology chemotherapy of ovarian fallopian tube Clinics and primary peritoneal cancers. Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
17/08 A multinational, randomised, double- Dr Gavin Marx 01-Apr-2008 Study Complete blind study comparing the efficacy of Sydney Haematology & Oncology Clinics Afibercept once every 2 weeks versus Sydney Haematology and Oncology placebo in patients with metastatic Clinics colorectal cancer (MCRC) treated with Clinical Trials Unit Irinotecan / 5-FU combination (FOLFIRI) Sydney Adventist Hospital after failure of Oxaliplatin based 185 Fox Valley Road regimen. Wahroonga NSW 2076
16/08 Chronic cough without wheeze or Dr Hugh Allen 19-Dec-2008 Study Complete shortness of breath in children may be Dept of Paediatrics, caused by upper airway obstruction Royal North Shore Hospital , Pacific Highway St Leonards NSW 2065
15/08 Influence of home monitoring on Dr Peter Illes 28-Jan-2009 Study Complete mortality and morbidity in heart failure 5 Bruce Street patients with an impaired left ventricular Mona Vale NSW 2103 function (IN-TIME) 14/08 A randomised, double-blind, placebo- Dr Meg Jardine 03-Dec-2008 Approved controlled, factorial-design trial to assess PO Box M201 the effect of aspirin and fish oil (omega-3 Missenden Road fatty acids) in the prevention of early thrombosis in arterio-venous fistulae in Camperdown NSW 2050 patients with Stage IV or V chronic kidney disease requiring haemodialysis. 13/08 Temporal trends in incidence of primary Dr Vini Khurana 29-Jan-2009 Study Complete brain tumours in the Australian Capital Dept of Neurosurgery, Territory and New South Wales: 1994 – The Canberra Hospital, 2008 PO Box 11 Woden ACT 2606
12/08 A randomized, double-blind, multicentre, Dr Gavin Marx 23-Oct-2008 Study Complete phase II/III study to compare the efficacy Sydney Haematology & Oncology Clinics of AZD2171 in combination with 5- Sydney Haematology and Oncology fluorouracil, leucovorin and oxaliplatin Clinics (FOLFOX), to the efficacy of Clinical Trials Unit bevacizumab in combination with Sydney Adventist Hospital FOLFOX in patients with previously 185 Fox Valley Road untreated metastatic colorectal cancer. Wahroonga NSW 2076 Protocol No: D8480C00013 Updated 10-Dec-2012
11/08 Haemostasis Registry Prof Peter Cameron 10-Oct-2008 Study Complete Haemostasis Registry, Dept of Epidemiology & Preventive Medicine, Monash University, The Alfred Hospital, Commercial Road Melbourne VIC 3004
10/08 Optimal programming to improve Dr Peter Illes Disposed mechanical indices, symptoms and 5 Bruce Street exercise in cardiac resynchronization Mona Vale NSW 2103 therapy (OPTIMISE CRT) 09/08 A phase II biomarker identification trial Dr Gavin Marx 10-Sep-2008 Study Complete for Erlotinib (Tarceva) in patients with Sydney Haematology & Oncology Clinics advanced pancreatic carcinoma. Sydney Haematology and Oncology Clinics Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
08/08 A phase II, dose escalation to rash trial Dr Gavin Marx 10-Sep-2008 Study Complete of Erlotinib (Tarceva) plus Gemcitabine Sydney Haematology & Oncology Clinics in patients with metastatic pancreatic Sydney Haematology and Oncology cancer. Clinics Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
07/08 Age at first birth, mode of conception Dr Catherine McMahon 03-Sep-2008 Study Complete and adjustment to parenthood. Senior Lecturer Psychology Psychology Dept, Macquarie University North Ryde NSW 2109
06/08 Neurobiological correlates of depression Dr Ross Grant 27-Aug-2008 Archived - Study in adolescents. CEO - Australasian Research Institute Complete Australasian Research Institute 185 Fox Valley Road Wahroonga NSW 2076
05/08 A phase 3 , randomised double-blind Dr Gavin Marx 14-Aug-2008 Study Complete placebo controlled study of Abiratone Sydney Haematology & Oncology Clinics Acetate (CB7630) plus prednisone in Sydney Haematology and Oncology patients with metastatic castration- Clinics resistant prostate cancer who have Clinical Trials Unit failed Docetaxel-based chemotherapy. Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
04/08 Phase I, single-centre, randomised, Dr Ross Grant 14-May-2008 Archived - Discontinued placebo controlled, fixed dose clinical CEO - Australasian Research Institute trial of the safety and efficacy of up to 14 Australasian Research Institute days application of Zb extract cream in 185 Fox Valley Road the treatment of subjects with common Wahroonga NSW 2076 warts.
03/08 To assess a level of satisfaction with Penman 22-May-2008 Study Complete PageWriter TC70 (VersionA.01.00) Director of Patient Flow Services cardiograph and the Triton PIM lead set Sydney Adventist Hospital for its functionality and performance
02/08 An international multi-centre open-label Dr Gavin Marx 09-Apr-2008 Approved 2-arm phase III trial of adjuvant Sydney Haematology & Oncology Clinics Bevacizumab in triple negative breast Sydney Haematology and Oncology cancer - BEATRICE Clinics Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
01/08 Neuro and Endocrine Tumour and Dr Diana Benn 09-Apr-2008 Study Complete Tissue Bank Senior Research Scientist Cancer Genetics Unit, Kolling Institute of Medical Research, Royal North Shore Hospital St Leonards NSW 2065
20/07 ACTIVE Dialysis – A Clinical Trial of Dr Paul Collett 12-Dec-2007 Study Complete IntensiVE Dialysis Director of Nephrology Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
19/07 CoolCath Trial – An international study Associate Professor Henry Woo 12-Dec-2007 Withdrawn to assess the safety and efficacy of the Australian Clinical Trials Pty Ltd CoolMaxTM microwave catheter. Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
18/07 Bed Head Elevation Study Dr Ian Baldwin 12-Dec-2007 Study Complete 145 Studley Rd Heidelberg VIC 3084
17/07 Quantification of NAD+ levels in normal Dr Ross Grant 12-Dec-2007 Approved human plasma: correlation with age and CEO - Australasian Research Institute oxidative stress. Australasian Research Institute 185 Fox Valley Road Wahroonga NSW 2076 Updated 10-Dec-2012
16/07 Does a tea-tree cleansing foam effect Gary Bain 12-Dec-2007 Disposed the bacterial flora of chronic leg ulcer Wound Clinic, wounds: a preliminary investigation. Sydney Adventist Hospital, 185 Fox Valley Road Wahroonga NSW 2076
15/07 Development of a semen-based test for Associate Professor Henry Woo 12-Dec-2007 Discontinued prostate cancer. Australian Clinical Trials Pty Ltd Australian Clinical Trials Pty Ltd Suite 406 SAN Clinic 185 Fox Valley Road Wahroonga NSW 2076
14/07 Automated Pacemaker Home Monitoring Dr Jason Sharp 29-Apr-2008 Study Complete Reduces the Need for Regular Routine Clinic Checks 13/07 Health services innovation grant for the Dr Barbara Newman 31-Oct-2007 Study Complete employment of a patient navigator – Patient Navigator, breast cancer. Clinical Services, Sydney Adventist Hospital, 185 Fox Valley Road Wahroonga NSW 2076
12/07 Portacath Survey Eisen Liang Disposed San Radiology
11/07 Breast Cancer Tissue Bank Professor Christine Clarke 05-Sep-2007 Approved unknown Westmead NSW 2145
10/07 An inquiry into the development of Sally Goss 10-Aug-2007 Study Complete support groups and their effects on the Project Coordinator, well-being of people with lung and Lung & Gynaecological Cancer Support, gynaecological cancer and their carers. Cancer Support Centre, Sydney Adventist Hospital, 185 Fox Valley Road Wahroonga NSW 2076
09/07 International Survey of patients with Wendy White 09-May-2007 Disposed chronic pain: their experience of pain. Clinical Nurse Consultant, Monash University, Wound Foundation of Australia, NSW Branch, PO Box 4665 Lake Haven NSW 2263
08/07 Measuring impact on patient nutritional Sarah Liston 30-May-2007 Disposed status in the highly dependent patient Manager Dietetics, before and after the implementation of a Sydney Adventist Hospital, feeding team*: “a focus on highly 185 Fox Valley Road dependent patients” Wahroonga NSW 2076
07/07 A 12-month double-blind, randomized, Prof Roy Beran 24-Apr-2007 Study Complete multicenter, active-controlled, parallel- Strategic Health Evaluators, group study comparing the efficacy and Suite 5, safety of 0.5mg and 1.25mg fingolimod 6th Floor, (FTY 720) administered orally once daily 12 Thomas Street versus interferon B-1a (Avonex Chatswood NSW 2067 ®)administered i.m. once weekly in patients with relapsing-remitting multiple sclerosis. (TRANSFORMS) Updated 10-Dec-2012
06/07 Proof of concept: an open label pilot Dr Ross Grant 04-Apr-2007 Study Complete study to determine the efficacy and CEO - Australasian Research Institute tolerability of a treated gliadin-containing Australasian Research Institute product (GCP) in asymptomatic subjects 185 Fox Valley Road with coeliac disease. Wahroonga NSW 2076
05/07 An international multi-centre study of Dr Gavin Marx 04-Apr-2007 Discontinued tamoxifen vs anastrozole in Sydney Haematology & Oncology Clinics postmenopausal women with hormone Sydney Haematology and Oncology sensitive ductal carcinoma in situ (DCIS) Clinics (IBIS II – DCIS). Clinical Trials Unit Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
04/07 The effect of diet and lifestyle on serum Dr Ross Grant 04-Apr-2007 Study Complete adipocytokine levels in adolescent CEO - Australasian Research Institute females: implications for insulin Australasian Research Institute resistance and Type 2 diabetes. 185 Fox Valley Road Wahroonga NSW 2076
03/07 Cognitive performance and closed loop 04-Apr-2007 Study Complete stimulation. (COGNITION)
02/07 A 12-month double-blind, randomized, A/Prof Robert Heard 07-Feb-2007 Study Complete multicenter, active-controlled, parallel- 55 Hills Street group study comparing the efficacy and Gosford NSW 2250 safety of 0.5mg and 1.25mg fingolimod (FTY 720) administered orally once daily versus interferon B-1a (Avonex â)administered i.m. once weekly in patients with relapsing-remitting multiple sclerosis. (TRANSFORMS) 01/07 New leaves poetry writing project. Ms Carolyn Rickett 04-Apr-2007 Study Complete PO Box 19 Cooranbong NSW 2265
25/06 A frequent optimization study using the Dr Peter Illes 07-Feb-2007 Study Complete QuickOpt Method. (FREEDOM) 5 Bruce Street Mona Vale NSW 2103
24/06 Randomised comparative study of Dr Gavin Marx 04-Oct-2006 Recruitment Ceased FOLFOX6m plus SIR-spheres versus Sydney Haematology & Oncology Clinics FOLFOX6m alone as first line treatment Sydney Haematology and Oncology in patients with non-resectable liver Clinics metastases from primary colorectal Clinical Trials Unit carcinoma. (SIRFLOX) Sydney Adventist Hospital 185 Fox Valley Road Wahroonga NSW 2076
23/06 Randomised, double-blind, placebo- 04-Oct-2006 Withdrawn controlled, parallel-group, dose-ranging study to investigate the MRI efficacy and the safety of six months administration of firategrast (150-1200mg twice daily) in subjects with relapsing-remitting multiple sclerosis. (TIME) 22/06 Responding to the needs and quality of 18-Dec-2006 Study Complete life experiences of advanced non-small cell lung cancer: a focus groups study of patients and carers. Updated 10-Dec-2012
21/06 Comparison of adipocytokine levels in 04-Oct-2006 Study Complete age, sex and BMI matched vegetarian versus non-vegetarian adults. 20/06 A phase III randomized, double-blind 04-Oct-2006 Withdrawn placebo-controlled, multicentre clinical trial of Rebif new formulation (44mcg tiw and 44 mcg ow) in subjects at high risk of converting to multiple sclerosis (REFLEX). 19/06 Pilot study for pathways to the diagnosis 04-Oct-2006 Disposed of thyroid cancer in NSW.
18/06 Audit of complication rates and 16-Nov-2006 Disposed outcomes from radiotherapy treatment of prostate cancer. 17/06 The effect of reflexology therapy on 04-Oct-2006 Study Complete cancer patients (particularly breast cancer). 16/06 Investigation of clinical endpoints for 02-Aug-2006 Study Complete treatment-induced gastroesophageal reflux disease (GERD) symptom changes. 15/06 A randomised single-blind study to 02-Aug-2006 Discontinued improve health-related quality of life as measured by the SF-36 vitality score by correcting anaemia of chronic kidney disease with Aranespâ in the elderly. (STIMULATE) 14/06 Sensory evaluation and taste threshold 07-Jun-2006 Disposed data of the minor components of soybeans in soy foods. 13/06 IBCSG 23-01 A randomised trial of 07-Jun-2006 Discontinued axillary dissection versus no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node. (IBCSG 23-01) 12/06 The effect lipid lowering agents on fat 07-Jun-2006 Study Complete metabolism during aerobic exercise in dyslipidemic individuals 11/06 A multi-centre randomized trial of 07-Jun-2006 Discontinued sentinel node versus axillary clearance in operable breast cancer.(SNAC2) 10/06 A long term non-interventional study to 16-Apr-2006 Study Complete evaluate the effectiveness of Aranesp in dialysis patients when administered once every two weeks. (ALTERNATE) 09/06 Evaluation of variance in the 05-Apr-2006 Study Complete immunogenic activity of hydrolysed selected wheat proteins using isolated human T-cells from celiac sufferers 08/06 A retrospective audit of patients 07-Jun-2006 Study Complete undergoing percutaneous closure of patent foramen ovale 07/06 A randomized, double-blind, placebo- 07-Jun-2006 Discontinued controlled, proof of concept study of Zoledronic acid in spontaneous osteonecrosis of the knee (SONK). (The Zo-SONK study). 06/06 Progesterone after previous preterm 07-Jun-2006 Archived - Discontinued birth for the prevention of neonatal respiratory distress syndrome. (PROGRESS) 05/06 Prospective comparison of the 05-Apr-2006 Discontinued immunological response following robotic assisted and open retropubic radical prostatectomy for organ confined prostate carcinoma. 04/06 A study of sharps injuries among SAH 05-Apr-2006 Study Complete staff following adoption of the Sharpsmart Safety Device. Updated 10-Dec-2012
03/06 A prospective, multicentre clinical trial to Dr William K Walter 05-Apr-2006 Study Complete evaluate functional outcomes and wear Specialist Orthopaedic Group, in alumina-Delta bearing surfaces, after Mater Clinic, primary uncemented total hip Suite 1.08, replacements. Level 1, 3-9 Gilles Street North Sydney NSW 2060
02/06 Pacing alternate sites using 05-Apr-2006 Study Complete SelectSecure. (PASSES) 01/06 Ethics Committee endorsement as an Dr David McHarg 01-Feb-2006 Approved Authorised Prescriber of an unapproved Practice Manager product under section 19(5) of the Northern Nuclear Medicine Therapeutic Goods Act. Suite 306 The San Clinic
185 Fox Valley Rd Wahroonga NSW 2076
09/05 Vitamin B12 supplementing efficacy of 17-Aug-2005 Archived - Study Propionibacterium jensenii 702 Complete
08/05 CT0501: Non-comparative, multi-centre Dr James Sullivan 06-Apr-2005 Recruitment Ceased study to evaluate the safety and efficacy SportsMed West, of DePuy Silent Hip prosthesis in 116 Macquarie Street primary total hip replacement. Parramatta NSW 2150
07/05 TVT-O prospective outcomes study 06-Apr-2005 Study Complete 05/05 Access to Medical Records 02-Feb-2005 Study Complete 04/05 Sydney – Newcastle Adventist Schools: 02-Feb-2005 Study Complete Teen physical activity and nutrition study
03/05 Exploring post operative delirium (POD) 02-Feb-2005 Disposed in the elective, major, colorectal surgical population 02/05 Anxiety in patients who undergo 02-Feb-2005 Disposed successful percutaneous coronary intervention (PCI) over time 01/05 Poster presentation of CT and X-ray 02-Feb-2005 Disposed case of paediatric osteomyelitis
20/04 Association of the Use of Adrenaline in 10-Nov-2004 Disposed Cardiac Arrest and Outcome, Particularly Stroke – A Case Study 18/04 National Midwifery Competencies 10-Nov-2004 Disposed Project 17/04 Colonoscopy Research in Symptom 01-Sep-2004 Study Complete Prediction (CRISP) 16/04 BotuliniumToxin Type A for Urinary 01-Sep-2004 Study Complete Urgency 15/04 Prospective Safety and efficacy study of 01-Sep-2004 Disposed the PTQ Implantation Procedure for the treatment of patients diagnosed with Passive Faecal Incontinence 14/04 A Sentinel Study of Cardiovascular 01-Sep-2004 Study Complete Disease Risk Factors in Australia
13/04 Developing and Understanding of Family 01-Sep-2004 Study Complete and Social influences on Children’s Physical Activity and Participation in a Community Sporting Event 12/04 Cancer Caregiver Needs Study. Pilot 01-Sep-2004 Disposed Study 11/04 Authorised Prescriber 01-Sep-2004 Disposed 10/04 Stress and Burnout within nursing and 05-May-2004 Disposed midwifery professions 09/04 Gluten-Free Wheat Trial. A pilot study. 05-May-2004 Disposed 08/04 The Determination of Glycaemic Index of Dr David Harris 31-May-2004 Approved Foods PO Box 40 COORANBONG NSW 2265 Updated 10-Dec-2012
07/04 Equol Production Ability of vegetarians 31-May-2004 Study Complete and non-vegetarians to convert daidzein to equol 06/04 Topical treatments for radiation induced 05-May-2004 Disposed skin responses: a repeated measures, comparative study of a tea tree oil and a paw paw cream dressing 05/04 Age induced changes in the Human 18-Feb-2004 Study Complete Urinary Bladder 04/04 Retrospective Review of Patients who 18-Feb-2004 Disposed underwent surgery for Prolapse at SAH
03/04 Prospective Safety and Efficacy study of 18-Feb-2004 Discontinued Midline Intravaginal Slingplasty for treatment of Urinary Stress Incontinence 02/04 Neurochemicals and their Receptors in 18-Feb-2004 Study Complete Human Urinary Bladder
01/04 Trial to Reduce the Incidence of Type 1 Dr Neville J Howard 18-Feb-2004 Archived - Study diabetes in the Genetically at Risk Institute of Endocrinology & Diabetes, Complete (TRIGR study) The Children’s Hospital at Westmead, Locked Bag 4001 Westmead NSW 2145
13/03 Detection of Human Chlamydia 12-Nov-2003 Study Complete pneumoniae infection 12/03 Stroke patients’ abilities to stand up and 12-Nov-2003 Disposed to walk after discharge from rehabilitation 11/03 Study of Heart and Renal Protection 12-Nov-2003 Study Complete (SHARP): a randomised placebo controlled study to assess the effects of cholesterol-lowering therapy with a combination of simvastatin and ezetimibe on the risk of major cardiovascular complications among individuals with renal impairment 10/03 Mental Fatigue after Walking Exercise 03-Sep-2003 Disposed 09/03 Safety and preliminary efficacy study for 03-Sep-2003 Study Complete the MiniaturoTMI system utilized for the treatment of patients diagnosed with interstitial cystitis (IC), overactive bladder (OAB) & urinary urge incontinence (UUI) 08/03 Volitional Strategies of Self-Regulation 03-Sep-2003 Disposed 07/03 Observational Study of Common 02-Mar-2003 Disposed remedies of nausea and vomiting during pregnancy 06/03 Control of proliferative lifespan in Human 07-Jul-2003 Study Complete Breast Epithelial Cells
05/03 Prayer Power Project Disposed 04/03 Characterisation of naturally occurring 19-Mar-2002 Study Complete variations in the cellular genes of children 03/03 Isolation and Cryopreservation of Cord 19-Mar-2002 Study Complete Blood Stem Cells. Setting up a Stem Cell Unit 02/03 AuSPEN Nutritional Support Study 19-Mar-2002 Study Complete 01/03 Transition Support Programs for New 19-Mar-2002 Disposed Graduate Nurses 15/02 A Sentinel Study of Trends in Coronary 11-Nov-2002 Disposed Heart Disease Risk Factors in Australia. ARC Linkage Project 14/02 Transition Support Programs for new 11-Nov-2002 Disposed Grad Nurses – How effective are they?
13/02 Characterisation of picolinic acid levels 06-Nov-2002 Study Complete and related metabolites in human cerebrospinal fluid and serum Updated 10-Dec-2012
11/02 Multicentre phase 3 open label study to 06-Nov-2002 Study Complete assess patient preference and sexual encounter attributes of men with switching from sildenafil citrate to tadalafil 20mg. 10/02 A Phenomenological Study of what is 01-Sep-2002 Disposed uniquely SDA in Operation of SAH
09/02 A pilot study to assess the clinical Dr James Sullivan 03-Jul-2002 Recruitment Ceased importance of the Silent Hip SportsMed West, 116 Macquarie Street Parramatta NSW 2150
08/02 Does Splinting prevent contracture 03-Jul-2002 Disposed following stroke 07/02 The lived experience of coping with renal 01-May-2002 Disposed disease and dialysis treatment
06/02 The re-invasion of the medicalised birth: 01-May-2002 Disposed An investigation into the desire for medical intervention during pregnancy and childbirth 05/02 Approval for use of interventional 01-May-2002 Disposed devices 04/02 The incidence and characteristics of pain 06-Mar-2002 Disposed (stump pain and phantom pain) and phantom sensations in amputees attending prosthetic clinics in Sydney 03/02 A clinical trial of the efficacy of the 06-Mar-2002 Disposed topical skin cream 101CSD to resolve superficial basal cell carcinoma 02/02 A prospective, multicentre, population- 06-Mar-2002 Disposed based laboratory surveillance for candidaemia in Australia over a three year period 01/02 ERCP Audit at Sydney Adventist 06-Mar-2002 Disposed Hospital 12/01 Survey of Occupational Health and 21-Mar-2001 Study Complete Safety Services in Hospitals
11/01 Concerns of caregivers of persons with 21-Mar-2001 Study Complete cancer 10/01 Australian Breast Cancer Family Study 21-Mar-2001 Study Complete 09/01 Temperament variables of personality as 21-Mar-2001 Study Complete modifiers of symptoms in stress burnout and burnt out individuals 08/01 The origins of antibiotic resistance genes 21-Mar-2001 Study Complete in multi-drug resistant clinical isolates
07/01 Stress and postnatal depression 21-Mar-2001 Study Complete 06/01 Initiating Dialysis Early and Late (IDEAL) 21-Mar-2001 Withdrawn 05/01 The use of electromyographic 21-Mar-2001 Study Complete biofeedback as an adjunct to occupational therapy in improving motor control of the upper limb after cerebrovascular accident 04/01 Not for Resuscitation (NFR) Policy 21-Mar-2001 Study Complete 03/01 Assessment of human prostate 21-Mar-2001 Study Complete pathology by in-vivo magnetic resonance imaging and spectroscopy 02/01 Socio-economic factors and patterns of 21-Mar-2001 Disposed care in lung cancer 01/01 The experience of newly registered 21-Mar-2001 Archived - Study nurses when faced with ethical situations Complete that challenge their personal values and belief systems